 | • レポートコード：MRC2102QY6751 • 出版社/出版日： / 2021年1月 • レポート形態：英文、PDF、140ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医薬品、医療 |
| Single User | ￥592,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥888,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,184,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYリサーチ社の本調査レポートでは、世界のヒト用ワクチン市場について種類別（バリセラ、インフルエンザ、ポリオ、A型肝炎、狂犬病、BCG、B型肝炎、百日咳、ジフテリア、破傷風、肺炎球菌、ロタワクチン）、用途別（大人、子供）、地域別（米国、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・ヒト用ワクチン市場の概要 ・世界の主要地域別ヒト用ワクチン市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界のヒト用ワクチン市場規模2015-2026：種類別（バリセラ、インフルエンザ、ポリオ、A型肝炎、狂犬病、BCG、B型肝炎、百日咳、ジフテリア、破傷風、肺炎球菌、ロタワクチン） ・世界のヒト用ワクチン市場規模2015-2026：用途別（大人、子供） ・ヒト用ワクチンの米国市場規模2015-2020 ・ヒト用ワクチンのヨーロッパ市場規模2015-2020 ・ヒト用ワクチンの中国市場規模2015-2020 ・ヒト用ワクチンの日本市場規模2015-2020 ・ヒト用ワクチンの東南アジア市場規模2015-2020 ・ヒト用ワクチンのインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 ・ヒト用ワクチンの製造コスト分析 ・販売チャネル、流通業者、顧客 ・ヒト用ワクチンの市場動向・機会・課題 ・調査の結論 |
A vaccine is a biological preparation that provides active acquired immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing microorganism and is often made from weakened or killed forms of the microbe, its toxins or one of its surface proteins.
China Human Vaccine is widely used for adults and children. The most proportion of China Human Vaccine is children, and the sales market share in 2017 is 64.6%.
Market Analysis and Insights: Global Human Vaccine Market
The global Human Vaccine market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026.
Global Human Vaccine Scope and Market Size
The global Human Vaccine market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Human Vaccine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2015-2026.
Segment by Type, the Human Vaccine market is segmented into
Varicella
Influenza
Polio
Hepatitis A
Rabies
BCG
Hepatitis B
Pertussis, Diphtheria, Tetanus
Pneumococcal
Rota vaccine
Segment by Application, the Human Vaccine market is segmented into
Adults
Children
The Human Vaccine market is analysed and market size information is provided by regions (countries). Segment by Application, the Human Vaccine market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Human Vaccine Market Share Analysis
Human Vaccine market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Human Vaccine business, the date to enter into the Human Vaccine market, Human Vaccine product introduction, recent developments, etc.
The major vendors covered:
CNBG
Changsheng Life
Zhifei
ChengDa Bio
Kangtai
SINOVAC BIOTECH
Hissen
Walvax Biotechnology
GSK
SANOFI
Rong An
NuoCheng Bio
Hualan Bio
Tiantan biological
Changchun Baike
Adimmune
Zhongyianke Biotech
1 Human Vaccine Market Overview
1.1 Human Vaccine Product Scope
1.2 Human Vaccine Segment by Type
1.2.1 Global Human Vaccine Sales by Type (2020-2026)
1.2.2 Varicella
1.2.3 Influenza
1.2.4 Polio
1.2.5 Hepatitis A
1.2.6 Rabies
1.2.7 BCG
1.2.8 Hepatitis B
1.2.9 Pertussis, Diphtheria, Tetanus
1.2.10 Pneumococcal
1.2.11 Rota vaccine
1.3 Human Vaccine Segment by Application
1.3.1 Global Human Vaccine Sales Comparison by Application (2020-2026)
1.3.2 Adults
1.3.3 Children
1.4 Human Vaccine Market Estimates and Forecasts (2015-2026)
1.4.1 Global Human Vaccine Sales Growth Rate (2015-2026)
1.4.2 Global Human Vaccine Revenue and Growth Rate (2015-2026)
1.4.3 Global Human Vaccine Price Trends (2015-2026)
2 Human Vaccine Estimate and Forecast by Region
2.1 Global Human Vaccine Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Human Vaccine Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Human Vaccine Sales Market Share by Region (2015-2020)
2.2.2 Global Human Vaccine Revenue Market Share by Region (2015-2020)
2.3 Global Human Vaccine Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Human Vaccine Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Human Vaccine Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Human Vaccine Estimates and Projections (2015-2026)
2.4.2 Europe Human Vaccine Estimates and Projections (2015-2026)
2.4.3 China Human Vaccine Estimates and Projections (2015-2026)
2.4.4 Japan Human Vaccine Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Human Vaccine Estimates and Projections (2015-2026)
2.4.6 India Human Vaccine Estimates and Projections (2015-2026)
3 Global Human Vaccine Competition Landscape by Players
3.1 Global Top Human Vaccine Players by Sales (2015-2020)
3.2 Global Top Human Vaccine Players by Revenue (2015-2020)
3.3 Global Human Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Human Vaccine as of 2019)
3.4 Global Human Vaccine Average Price by Company (2015-2020)
3.5 Manufacturers Human Vaccine Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Human Vaccine Players (Opinion Leaders)
4 Global Human Vaccine Market Size by Type
4.1 Global Human Vaccine Historic Market Review by Type (2015-2020)
4.1.1 Global Human Vaccine Sales Market Share by Type (2015-2020)
4.1.2 Global Human Vaccine Revenue Market Share by Type (2015-2020)
4.1.3 Global Human Vaccine Price by Type (2015-2020)
4.2 Global Human Vaccine Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Human Vaccine Sales Forecast by Type (2021-2026)
4.2.2 Global Human Vaccine Revenue Forecast by Type (2021-2026)
4.2.3 Global Human Vaccine Price Forecast by Type (2021-2026)
5 Global Human Vaccine Market Size by Application
5.1 Global Human Vaccine Historic Market Review by Application (2015-2020)
5.1.1 Global Human Vaccine Sales Market Share by Application (2015-2020)
5.1.2 Global Human Vaccine Revenue Market Share by Application (2015-2020)
5.1.3 Global Human Vaccine Price by Application (2015-2020)
5.2 Global Human Vaccine Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Human Vaccine Sales Forecast by Application (2021-2026)
5.2.2 Global Human Vaccine Revenue Forecast by Application (2021-2026)
5.2.3 Global Human Vaccine Price Forecast by Application (2021-2026)
6 United States Human Vaccine Market Facts & Figures
6.1 United States Human Vaccine Sales Market Share by Company (2015-2020)
6.2 United States Human Vaccine Sales Market Share by Type (2015-2020)
6.3 United States Human Vaccine Sales Market Share by Application (2015-2020)
7 Europe Human Vaccine Market Facts & Figures
7.1 Europe Human Vaccine Sales Market Share by Company (2015-2020)
7.2 Europe Human Vaccine Sales Market Share by Type (2015-2020)
7.3 Europe Human Vaccine Sales Market Share by Application (2015-2020)
8 China Human Vaccine Market Facts & Figures
8.1 China Human Vaccine Sales Market Share by Company (2015-2020)
8.2 China Human Vaccine Sales Market Share by Type (2015-2020)
8.3 China Human Vaccine Sales Market Share by Application (2015-2020)
9 Japan Human Vaccine Market Facts & Figures
9.1 Japan Human Vaccine Sales Market Share by Company (3015-3030)
9.2 Japan Human Vaccine Sales Market Share by Type (2015-2020)
9.3 Japan Human Vaccine Sales Market Share by Application (2015-2020)
10 Southeast Asia Human Vaccine Market Facts & Figures
10.1 Southeast Asia Human Vaccine Sales Market Share by Company (2015-2020)
10.2 Southeast Asia Human Vaccine Sales Market Share by Type (2015-2020)
10.3 Southeast Asia Human Vaccine Sales Market Share by Application (2015-2020)
11 India Human Vaccine Market Facts & Figures
11.1 India Human Vaccine Sales Market Share by Company (2015-2020)
11.2 India Human Vaccine Sales Market Share by Type (2015-2020)
11.3 India Human Vaccine Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Human Vaccine Business
12.1 CNBG
12.1.1 CNBG Corporation Information
12.1.2 CNBG Business Overview
12.1.3 CNBG Human Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.1.4 CNBG Human Vaccine Products Offered
12.1.5 CNBG Recent Development
12.2 Changsheng Life
12.2.1 Changsheng Life Corporation Information
12.2.2 Changsheng Life Business Overview
12.2.3 Changsheng Life Human Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Changsheng Life Human Vaccine Products Offered
12.2.5 Changsheng Life Recent Development
12.3 Zhifei
12.3.1 Zhifei Corporation Information
12.3.2 Zhifei Business Overview
12.3.3 Zhifei Human Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Zhifei Human Vaccine Products Offered
12.3.5 Zhifei Recent Development
12.4 ChengDa Bio
12.4.1 ChengDa Bio Corporation Information
12.4.2 ChengDa Bio Business Overview
12.4.3 ChengDa Bio Human Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.4.4 ChengDa Bio Human Vaccine Products Offered
12.4.5 ChengDa Bio Recent Development
12.5 Kangtai
12.5.1 Kangtai Corporation Information
12.5.2 Kangtai Business Overview
12.5.3 Kangtai Human Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Kangtai Human Vaccine Products Offered
12.5.5 Kangtai Recent Development
12.6 SINOVAC BIOTECH
12.6.1 SINOVAC BIOTECH Corporation Information
12.6.2 SINOVAC BIOTECH Business Overview
12.6.3 SINOVAC BIOTECH Human Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.6.4 SINOVAC BIOTECH Human Vaccine Products Offered
12.6.5 SINOVAC BIOTECH Recent Development
12.7 Hissen
12.7.1 Hissen Corporation Information
12.7.2 Hissen Business Overview
12.7.3 Hissen Human Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Hissen Human Vaccine Products Offered
12.7.5 Hissen Recent Development
12.8 Walvax Biotechnology
12.8.1 Walvax Biotechnology Corporation Information
12.8.2 Walvax Biotechnology Business Overview
12.8.3 Walvax Biotechnology Human Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Walvax Biotechnology Human Vaccine Products Offered
12.8.5 Walvax Biotechnology Recent Development
12.9 GSK
12.9.1 GSK Corporation Information
12.9.2 GSK Business Overview
12.9.3 GSK Human Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.9.4 GSK Human Vaccine Products Offered
12.9.5 GSK Recent Development
12.10 SANOFI
12.10.1 SANOFI Corporation Information
12.10.2 SANOFI Business Overview
12.10.3 SANOFI Human Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.10.4 SANOFI Human Vaccine Products Offered
12.10.5 SANOFI Recent Development
12.11 Rong An
12.11.1 Rong An Corporation Information
12.11.2 Rong An Business Overview
12.11.3 Rong An Human Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.11.4 Rong An Human Vaccine Products Offered
12.11.5 Rong An Recent Development
12.12 NuoCheng Bio
12.12.1 NuoCheng Bio Corporation Information
12.12.2 NuoCheng Bio Business Overview
12.12.3 NuoCheng Bio Human Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.12.4 NuoCheng Bio Human Vaccine Products Offered
12.12.5 NuoCheng Bio Recent Development
12.13 Hualan Bio
12.13.1 Hualan Bio Corporation Information
12.13.2 Hualan Bio Business Overview
12.13.3 Hualan Bio Human Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.13.4 Hualan Bio Human Vaccine Products Offered
12.13.5 Hualan Bio Recent Development
12.14 Tiantan biological
12.14.1 Tiantan biological Corporation Information
12.14.2 Tiantan biological Business Overview
12.14.3 Tiantan biological Human Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.14.4 Tiantan biological Human Vaccine Products Offered
12.14.5 Tiantan biological Recent Development
12.15 Changchun Baike
12.15.1 Changchun Baike Corporation Information
12.15.2 Changchun Baike Business Overview
12.15.3 Changchun Baike Human Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.15.4 Changchun Baike Human Vaccine Products Offered
12.15.5 Changchun Baike Recent Development
12.16 Adimmune
12.16.1 Adimmune Corporation Information
12.16.2 Adimmune Business Overview
12.16.3 Adimmune Human Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.16.4 Adimmune Human Vaccine Products Offered
12.16.5 Adimmune Recent Development
12.17 Zhongyianke Biotech
12.17.1 Zhongyianke Biotech Corporation Information
12.17.2 Zhongyianke Biotech Business Overview
12.17.3 Zhongyianke Biotech Human Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.17.4 Zhongyianke Biotech Human Vaccine Products Offered
12.17.5 Zhongyianke Biotech Recent Development
13 Human Vaccine Manufacturing Cost Analysis
13.1 Human Vaccine Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Human Vaccine
13.4 Human Vaccine Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Human Vaccine Distributors List
14.3 Human Vaccine Customers
15 Market Dynamics
15.1 Human Vaccine Market Trends
15.2 Human Vaccine Opportunities and Drivers
15.3 Human Vaccine Market Challenges
15.4 Human Vaccine Market Restraints
15.5 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Human Vaccine Sales (M Doses) Growth Rate by Type (2020-2026) (US$ Million)
Table 2. Global Human Vaccine Sales (M Doses) Comparison by Application (2020-2026) (US$ Million)
Table 3. Global Market Human Vaccine Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 4. Global Human Vaccine Sales (M Doses) by Region (2015-2020)
Table 5. Global Human Vaccine Sales Market Share by Region (2015-2020)
Table 6. Global Human Vaccine Revenue (US$ Million) Market Share by Region (2015-2020))
Table 7. Global Human Vaccine Revenue Share by Region (2015-2020)
Table 8. Global Human Vaccine Sales (M Doses) Forecast by Region (2021-2026)
Table 9. Global Human Vaccine Sales Market Share Forecast by Region (2021-2026)
Table 10. Global Human Vaccine Revenue (US$ Million) Forecast by Region (2021-2026)
Table 11. Global Human Vaccine Revenue Share Forecast by Region (2021-2026)
Table 12. Global Human Vaccine (M Doses) of Key Companies (2015-2020)
Table 13. Global Human Vaccine Sales Share by Company (2015-2020)
Table 14. Global Human Vaccine Revenue (US$ Million) by Company (2015-2020)
Table 15. Global Human Vaccine Revenue Share by Company (2015-2020)
Table 16. Global Human Vaccine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Human Vaccine as of 2019)
Table 17. Global Human Vaccine Average Price (USD/Dose) of Key Company (2015-2020)
Table 18. Manufacturers Human Vaccine Manufacturing Sites and Area Served
Table 19. Manufacturers Human Vaccine Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Main Points Interviewed from Key Human Vaccine Players
Table 22. Global Human Vaccine Sales (M Doses) by Type (2015-2020)
Table 23. Global Human Vaccine Sales Share by Type (2015-2020)
Table 24. Global Human Vaccine Revenue (US$ Million) Market Share by Type (2015-2020)
Table 25. Global Human Vaccine Price (M Doses) by Type (2015-2020)
Table 26. Global Human Vaccine Sales Share by Type (2021-2026)
Table 27. Global Human Vaccine Revenue (US$ Million) Market Share by Type (2021-2026)
Table 28. Global Human Vaccine Revenue Share by Type (2021-2026)
Table 29. Global Human Vaccine Price (M Doses) by Type (2021-2026)
Table 30. Global Human Vaccine Sales (M Doses) by Application (2015-2020)
Table 31. Global Human Vaccine Sales Share by Application (2015-2020)
Table 32. Global Human Vaccine Revenue (US$ Million) Market Share by Application (2015-2020)
Table 33. Global Human Vaccine Price (M Doses) by Application (2015-2020)
Table 34. Global Human Vaccine Sales (M Doses) by Application (2021-2026)
Table 35. Global Human Vaccine Sales Share by Application (2021-2026)
Table 36. Global Human Vaccine Revenue (US$ Million) Market Share by Application (2021-2026)
Table 37. Global Human Vaccine Revenue Share by Application (2021-2026)
Table 38. Global Human Vaccine Price (M Doses) by Application (2021-2026)
Table 39. United States Human Vaccine Sales (M Doses) by Company (2015-2020)
Table 40. United States Human Vaccine Sales Market Share by Company (2015-2020)
Table 41. United States Human Vaccine Sales (M Doses) by Type (2015-2020)
Table 42. United States Human Vaccine Sales Market Share by Type (2015-2020)
Table 43. United States Human Vaccine Sales (M Doses) by Application (2015-2020)
Table 44. United States Human Vaccine Sales Market Share by Application (2015-2020)
Table 45. Europe Human Vaccine Sales (M Doses) by Company (2015-2020)
Table 46. Europe Human Vaccine Sales Market Share by Company (2015-2020)
Table 47. Europe Human Vaccine Sales (M Doses) by Type (2015-2020)
Table 48. Europe Human Vaccine Sales Market Share by Type (2015-2020)
Table 49. Europe Human Vaccine Sales (M Doses) by Application (2015-2020)
Table 50. Europe Human Vaccine Sales Market Share by Type (2015-2020)
Table 51. China Human Vaccine Sales (M Doses) by Company (2015-2020)
Table 52. China Human Vaccine Sales Market Share by Company (2015-2020)
Table 53. China Human Vaccine Sales (M Doses) by Type (2015-2020)
Table 54. China Human Vaccine Sales Market Share by Type (2015-2020)
Table 55. China Human Vaccine Sales (M Doses) by Application (2015-2020)
Table 56. China Human Vaccine Sales Market Share by Application (2015-2020)
Table 57. Japan Human Vaccine Sales (M Doses) by Company (2015-2020)
Table 58. Japan Human Vaccine Sales Market Share by Company (2015-2020)
Table 59. Japan Human Vaccine Sales (M Doses) by Type (2015-2020)
Table 60. Japan Human Vaccine Sales Market Share by Type (2015-2020)
Table 61. Japan Human Vaccine Sales (M Doses) by Application (2015-2020)
Table 62. Japan Human Vaccine Sales Market Share by Application (2015-2020)
Table 63. Southeast Asia Human Vaccine Sales (M Doses) by Company (2015-2020)
Table 64. Southeast Asia Human Vaccine Sales Market Share by Company (2015-2020)
Table 65. Southeast Asia Human Vaccine Sales (M Doses) by Type (2015-2020)
Table 66. Southeast Asia Human Vaccine Sales Market Share by Type (2015-2020)
Table 67. Southeast Asia Human Vaccine Sales (M Doses) by Type (2015-2020)
Table 68. Southeast Asia Human Vaccine Sales Market Share by Application (2015-2020)
Table 69. India Human Vaccine Sales (M Doses) by Company (2015-2020)
Table 70. India Human Vaccine Sales Market Share by Company (2015-2020)
Table 71. India Human Vaccine Sales (M Doses) by Type (2015-2020)
Table 72. India Human Vaccine Sales Market Share by Type (2015-2020)
Table 73. India Human Vaccine Sales (M Doses) by Application (2015-2020)
Table 74. India Human Vaccine Sales Market Share by Application (2015-2020)
Table 75. CNBG Corporation Information
Table 76. CNBG Description and Business Overview
Table 77. CNBG Human Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 78. CNBG Human Vaccine Product
Table 79. CNBG Recent Development
Table 80. Changsheng Life Corporation Information
Table 81. Changsheng Life Description and Business Overview
Table 82. Changsheng Life Human Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 83. Changsheng Life Human Vaccine Product
Table 84. Changsheng Life Recent Development
Table 85. Zhifei Corporation Information
Table 86. Zhifei Description and Business Overview
Table 87. Zhifei Human Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 88. Zhifei Human Vaccine Product
Table 89. Zhifei Recent Development
Table 90. ChengDa Bio Corporation Information
Table 91. ChengDa Bio Description and Business Overview
Table 92. ChengDa Bio Human Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 93. ChengDa Bio Human Vaccine Product
Table 94. ChengDa Bio Recent Development
Table 95. Kangtai Corporation Information
Table 96. Kangtai Description and Business Overview
Table 97. Kangtai Human Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 98. Kangtai Human Vaccine Product
Table 99. Kangtai Recent Development
Table 100. SINOVAC BIOTECH Corporation Information
Table 101. SINOVAC BIOTECH Description and Business Overview
Table 102. SINOVAC BIOTECH Human Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 103. SINOVAC BIOTECH Human Vaccine Product
Table 104. SINOVAC BIOTECH Recent Development
Table 105. Hissen Corporation Information
Table 106. Hissen Description and Business Overview
Table 107. Hissen Human Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 108. Hissen Human Vaccine Product
Table 109. Hissen Recent Development
Table 110. Walvax Biotechnology Corporation Information
Table 111. Walvax Biotechnology Human Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 112. Walvax Biotechnology Description and Business Overview
Table 113. Walvax Biotechnology Human Vaccine Product
Table 114. Walvax Biotechnology Recent Development
Table 115. GSK Corporation Information
Table 116. GSK Human Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 117. GSK Description and Business Overview
Table 118. GSK Human Vaccine Product
Table 119. GSK Recent Development
Table 120. SANOFI Corporation Information
Table 121. SANOFI Description and Business Overview
Table 122. SANOFI Human Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 123. SANOFI Human Vaccine Product
Table 124. SANOFI Recent Development
Table 125. Rong An Corporation Information
Table 126. Rong An Description and Business Overview
Table 127. Rong An Human Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 128. Rong An Human Vaccine Product
Table 129. Rong An Recent Development
Table 130. NuoCheng Bio Corporation Information
Table 131. NuoCheng Bio Description and Business Overview
Table 132. NuoCheng Bio Human Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 133. NuoCheng Bio Human Vaccine Product
Table 134. NuoCheng Bio Recent Development
Table 135. Hualan Bio Corporation Information
Table 136. Hualan Bio Description and Business Overview
Table 137. Hualan Bio Human Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 138. Hualan Bio Human Vaccine Product
Table 139. Hualan Bio Recent Development
Table 140. Tiantan biological Corporation Information
Table 141. Tiantan biological Description and Business Overview
Table 142. Tiantan biological Human Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 143. Tiantan biological Human Vaccine Product
Table 144. Tiantan biological Recent Development
Table 145. Changchun Baike Corporation Information
Table 146. Changchun Baike Description and Business Overview
Table 147. Changchun Baike Human Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 148. Changchun Baike Human Vaccine Product
Table 149. Changchun Baike Recent Development
Table 150. Adimmune Corporation Information
Table 151. Adimmune Description and Business Overview
Table 152. Adimmune Human Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 153. Adimmune Human Vaccine Product
Table 154. Adimmune Recent Development
Table 155. Zhongyianke Biotech Corporation Information
Table 156. Zhongyianke Biotech Description and Business Overview
Table 157. Zhongyianke Biotech Human Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 158. Zhongyianke Biotech Human Vaccine Product
Table 159. Zhongyianke Biotech Recent Development
Table 160. Production Base and Market Concentration Rate of Raw Material
Table 161. Key Suppliers of Raw Materials
Table 162. Human Vaccine Distributors List
Table 163. Human Vaccine Customers List
Table 164. Human Vaccine Market Key Trends
Table 165. Human Vaccine Key Opportunities and Drivers
Table 166. Human Vaccine Market Challenges
Table 167. Research Programs/Design for This Report
Table 168. Key Data Information from Secondary Sources
Table 169. Key Data Information from Primary Sources
List of Figures
Figure 1. Human Vaccine Product Picture
Figure 2. Global Human Vaccine Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Human Vaccine Market Share by Application in 2020 & 2026
Figure 6. Adults Examples
Figure 7. Children Examples
Figure 8. Global Human Vaccine Sales (M Doses) Growth Rate (2015-2026)
Figure 9. Global Human Vaccine Revenue (US$ Million) Growth Rate (2015-2026)
Figure 10. Global Human Vaccine Price Trends Growth Rate (2015-2026) (USD/Dose)
Figure 11. Global Human Vaccine Revenue Market Share by Region: 2015 VS 2020
Figure 12. Global Human Vaccine Revenue Market Share by Region: 2021 VS 2026
Figure 13. United States Human Vaccine Revenue (Million USD) Growth Rate (2015-2026)
Figure 14. United States Human Vaccine Sales (M Doses) Growth Rate (2015-2026)
Figure 15. Europe Human Vaccine Revenue (Million USD) Growth Rate (2015-2026)
Figure 16. Europe Human Vaccine Sales (Million USD) Growth Rate (2015-2026)
Figure 17. China Human Vaccine Revenue (Million USD) Growth Rate (2015-2026)
Figure 18. China Human Vaccine Sales (Million USD) and Growth Rate (2015-2026)
Figure 19. Japan Human Vaccine Revenue (Million USD) Growth Rate (2015-2026)
Figure 20. Japan Human Vaccine Sales (Million USD) Growth Rate (2015-2026)
Figure 21. Southeast Asia Human Vaccine Revenue (Million USD) Growth Rate (2015-2026)
Figure 22. Southeast Asia Human Vaccine Sales (Million USD) Growth Rate (2015-2026)
Figure 23. India Human Vaccine Revenue (Million USD) Growth Rate (2015-2026)
Figure 24. India Human Vaccine Sales (Million USD) Growth Rate (2015-2026)
Figure 25. Global 5 Largest Human Vaccine Players Market Share by Revenue in Human Vaccine 2015 & 2019
Figure 26. Human Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 27. Global Human Vaccine Revenue Share by Type (2015-2020)
Figure 28. Global Human Vaccine Revenue Growth Rate by Type in 2015 & 2019
Figure 29. Global Human Vaccine Revenue Share by Application (2015-2020)
Figure 30. Global Human Vaccine Revenue Growth Rate by Application in 2015 & 2019
Figure 31. United States Human Vaccine Sales Market Share by Type in 2019
Figure 32. United States Human Vaccine Sales Market Share by Type in 2019
Figure 33. Europe Human Vaccine Sales Market Share by Company in 2019
Figure 34. Europe Human Vaccine Sales Market Share by Type in 2019
Figure 35. Europe Human Vaccine Sales Market Share by Application in 2019
Figure 36. China Human Vaccine Sales Market Share by Company in 2019
Figure 37. China Human Vaccine Sales Market Share by Type in 2019
Figure 38. China Human Vaccine Sales Market Share by Application in 2019
Figure 39. Japan Human Vaccine Sales Market Share by Company in 2019
Figure 40. Japan Human Vaccine Sales Market Share by Type in 2019
Figure 41. Japan Human Vaccine Sales Market Share by Application in 2019
Figure 42. Southeast Asia Human Vaccine Sales Market Share by Company in 2019
Figure 43. Southeast Asia Human Vaccine Sales Market Share by Type in 2019
Figure 44. Southeast Asia Human Vaccine Sales Market Share by Application in 2019
Figure 45. India Human Vaccine Sales Market Share by Company in 2019
Figure 46. India Human Vaccine Sales Market Share by Type in 2019
Figure 47. India Human Vaccine Sales Market Share by Application in 2019
Figure 48. Key Raw Materials Price Trend
Figure 49. Manufacturing Cost Structure of Human Vaccine
Figure 50. Manufacturing Process Analysis of Human Vaccine
Figure 51. Human Vaccine Industrial Chain Analysis
Figure 52. Channels of Distribution
Figure 53. Distributors Profiles
Figure 54. Porter's Five Forces Analysis
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed
23価肺炎球菌多糖体ワクチンの世界市場レポート2020 23-Valent Pneumococcal Polysaccharide Vaccine is a kind of vaccine used to prevent infection caused by pneumococcal bacteria. 23-Valent Pneumococcal Polysaccharide Vaccine contains 23 of the most common types of pneumococcal bacteria. 23-Valent Pneumococcal Polysaccharide Vaccine is for use only in …- 水痘ワクチンの世界市場レポート2020 Varicella vaccine, also known as chickenpox vaccine, is a vaccine that protects against chickenpox. One dose of vaccine prevents 95% of moderate disease and 100% of severe disease. Two doses of vaccine is more effective than one. If given to those who are not immune within five days of exposure to c…
- 弱毒生水痘ワクチンの世界市場レポート2020 A live attenuated varicella vaccine, derived from the Oka strain of VZV has clinical efficacy for the prevention of varicella. The downstream industries of varicella attenuated live vaccine products are kids and adults. In the recent years, with the recovery of global economic, the development of em…
- 水痘（水疱瘡）ワクチンの世界市場レポート2020 Market Analysis and Insights: Global Chickenpox (Varicella) Vaccine Market The global Chickenpox (Varicella) Vaccine market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026. Global Chickenpox (Varicella) Vaccine Scope and Market Size T…
- 狂犬病ワクチンの世界市場レポート2020 Rabies vaccine is an active immunizing agent used to prevent infection caused by the rabies virus. The vaccine works by causing your body to produce its own protection (antibodies) against the rabies virus. Every year more than 5.5 million people have died for rabies, mostly in Asia and Africa. With…